NeuroOne (Nasdaq:NMTC) announced today that it filed an FDA 510(k) submission for its trigeminal nerve ablation technology.

It helps to relieve spine and neck pain ... (only upon instruction by the healthcare provider). For the nerve ablation ...

Chronic spine pain ... While interventional procedures such as epidural steroid injections, nerve blocks, and radiofrequency ...

Ablation of the posterior nasal nerve leads to durable reductions in symptoms of chronic rhinitis, new research shows.

NeuroOne submits FDA filing early for trigeminal nerve ablation using its OneRF system as the facial pain market sees projected growth to $416 million by 2030.

"The SynerFuse™ proof-of-concept study demonstrated the safety and feasibility of integrating direct nerve stimulation ... who undergo traditional spinal fusion surgery in the United States ...

Interventional pain management uses special tools and techniques to diagnose and treat pain, especially when regular methods like medicine or physical therapy fail to provide adequate relief.